Davis's Drug Guide
fruquintinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
frew-kwin-ti-nib
Trade Name(s)
- Fruzaqla
Ther. Class.
Pharm. Class.
vascular endothelial growth factor antagonists
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Fruquintinib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580016/1/fruquintinib.
Vallerand AHA, Sanoski CAC, . Fruquintinib. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580016/1/fruquintinib. Accessed November 3, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Fruquintinib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580016/1/fruquintinib
Vallerand AHA, Sanoski CAC, . Fruquintinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 November 03]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580016/1/fruquintinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - fruquintinib
ID - 3580016
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580016/1/fruquintinib
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
